Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin

Leuk Lymphoma. 2012 Nov;53(11):2283-6. doi: 10.3109/10428194.2012.676170. Epub 2012 Apr 23.

Authors

Nina D Wagner-Johnston, Nancy L Bartlett, Amanda Cashen, Joseph R Berger

PMID: 22424602
DOI: 10.3109/10428194.2012.676170

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Brentuximab Vedotin
Hodgkin Disease / drug therapy*
Humans
Immunoconjugates / adverse effects*
Leukoencephalopathy, Progressive Multifocal / chemically induced*
Male
Middle Aged

Substances

Immunoconjugates
Brentuximab Vedotin